Elevatus Welath Management »

Recursion Pharmaceuticals shares owned by Elevatus Welath Management

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Elevatus Welath Management from 13F filings

Historical chart of Elevatus Welath Management investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by Elevatus Welath Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by Elevatus Welath Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.6M 343k 7.50
2024-03-31 $296k 30k 9.97
2023-12-31 $243k 25k 9.86

More positions owned by Elevatus Welath Management

Spdr Ser Tr Portfolio S&p600 (SPSM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Direxion Shs Etf Tr Dly Smcap Bull3x (TNA)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Amazon (AMZN)
Invesco Actively Managed Exc Aaa Clo Fltng Rt (ICLO)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
International Business Machines (IBM)
BlackRock
Quanta Services (PWR)

View all positions for Elevatus Welath Management

Top funds holding Recursion Pharmaceuticals

ARK Investment Management
Baillie Gifford & Co
Vanguard Group
BlackRock
RA Capital Management
Mubadala Investment Co PJSC
State Street Corporation
Kinnevik AB
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
MIC Capital Management UK
FMR
Nvidia Corp
Data Collective IV GP
Geode Capital Management

View all funds holding Recursion Pharmaceuticals